These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12678861)

  • 1. Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers.
    Buchwald UK; Pirofski L
    Curr Pharm Des; 2003; 9(12):945-68. PubMed ID: 12678861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulators as an antimicrobial tool.
    Pirofski LA; Casadevall A
    Curr Opin Microbiol; 2006 Oct; 9(5):489-95. PubMed ID: 16931122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies.
    Vinh DC
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1069-100. PubMed ID: 24881679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy for infectious diseases: challenges and prospects].
    Karaulov AV; Kaliuzhin OV
    Ter Arkh; 2013; 85(11):100-8. PubMed ID: 24432609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antibodies in the treatment of infectious diseases.
    Chan CE; Chan AH; Hanson BJ; Ooi EE
    Singapore Med J; 2009 Jul; 50(7):663-72; quiz 673. PubMed ID: 19644620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for pathogen-specific therapy.
    Casadevall A
    Expert Opin Pharmacother; 2009 Aug; 10(11):1699-703. PubMed ID: 19558338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy and vaccination after transplant: the present, the future.
    Emery VC; Einsele H; Atabani S; Haque T
    Infect Dis Clin North Am; 2010 Jun; 24(2):515-29. PubMed ID: 20466281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory approaches for prevention and treatment of infectious diseases.
    Nijnik A
    Curr Opin Microbiol; 2013 Oct; 16(5):590-5. PubMed ID: 23870826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage.
    Pirofski LA; Casadevall A
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crisis in infectious diseases: time for a new paradigm?
    Casadevall A
    Clin Infect Dis; 1996 Oct; 23(4):790-4. PubMed ID: 8909846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy and vaccination against infectious diseases.
    Ebbers M; Hemmer CJ; Müller-Hilke B; Reisinger EC
    Wien Klin Wochenschr; 2021 Jul; 133(13-14):714-720. PubMed ID: 33326055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is infectiveness and how is it involved in infection and immunity?
    Pirofski LA; Casadevall A
    BMC Immunol; 2015 Mar; 16():13. PubMed ID: 25887484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-directed immunotherapy to fight infectious diseases.
    Langelier MJ; Vinh DC
    Curr Opin Pediatr; 2022 Dec; 34(6):616-624. PubMed ID: 36081357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulators as adjuvants for vaccines and antimicrobial therapy.
    Nicholls EF; Madera L; Hancock RE
    Ann N Y Acad Sci; 2010 Dec; 1213():46-61. PubMed ID: 20946578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens.
    Garai P; Gogoi M; Gopal G; Radhakrishnan Y; Nandakumar KS; Chakravortty D
    Expert Opin Biol Ther; 2014 Oct; 14(10):1383-97. PubMed ID: 24897303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural product derived immune-regulatory agents.
    Talmadge JE
    Int Immunopharmacol; 2016 Aug; 37():5-15. PubMed ID: 26968760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of biologic response modifiers in infectious disease.
    Masihi KN; Schäfer H
    Infect Dis Clin North Am; 2011 Dec; 25(4):723-31. PubMed ID: 22054752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial immunotherapies for infectious diseases.
    Hengel H; Masihi KN
    Int Immunopharmacol; 2003 Aug; 3(8):1159-67. PubMed ID: 12860171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological response modifiers: current use and future prospects in cancer therapy.
    Bisht M; Bist SS; Dhasmana DC
    Indian J Cancer; 2010; 47(4):443-51. PubMed ID: 21131760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.